Abdominal and pelvic CEST imaging: quantitative assessment of tissue function, tumor characteristic, tumor aggressiveness

Abdominal and pelvic CEST imaging: quantitative assessment of tissue function, tumor characteristic, tumor aggressiveness - Abdominal and pelvic CEST imaging: quantitative assessment of tissue function, tumor characteristic, tumor aggressiveness

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017546

Enrollment

500

Registered

2015-05-13

Start date

2012-10-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Normal tissues and malignant tumors of liver, pancreas, kidney, uterus, prostate and GI

Interventions

With or without CEST imaging

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: MRI was performed for the evaluation abdominal or pelvic tumor. Informed consent was obtained. Equal or more than 20 years old

Exclusion criteria

Exclusion criteria: Contraindication of MRI

Design outcomes

Primary

Measure	Time frame
Comparison of CEST effects between tumor and non-tumor region. Assessment of diagnostic capability of tumor aggressiveness and histological characteristics by radiological-histological correlation.	—

Countries

Japan

Contacts

Public ContactYukihisa Takayama

Kyushu University Department of Clinical Radiology

ytaka@radiol.med.kyushu-u.ac.jp092-642-5695

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026